Nedaplatin and irinotecan combination therapy is equally effective and less toxic than cisplatin and irinotecan for patients with primary clear cell adenocarcinoma of the ovary and recurrent ovarian carcinoma

This study retrospectively compared nedaplatin and irinotecan hydrochloride (NDP/CPT) combination therapy with cisplatin and irinotecan hydrochloride therapy (CDDP/CPT) for efficacy and adverse events in the treatment of clear cell adenocarcinoma of the ovary (CCC) and recurrent ovarian carcinoma. A...

Full description

Saved in:
Bibliographic Details
Main Authors: MACHIDA, SHIZUO, SATO, TOMOMI, FUJIWARA, HIROYUKI, SAGA, YASUSHI, TAKEI, YUJI, TANEICHI, AKIYO, NONAKA, HIROAKI, SUZUKI, MITSUAKI
Format: Artigo
Language:Inglês
Published: D.A. Spandidos 2012
Subjects:
Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3499502/
https://ncbi.nlm.nih.gov/pubmed/23162643
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2012.853
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items